PL350088A1 - Novel method for producing doxazosin mesylate in a crystalline modification designated as form a - Google Patents

Novel method for producing doxazosin mesylate in a crystalline modification designated as form a

Info

Publication number: PL350088A1
Authority: PL; Poland
Prior art keywords: novel method; crystalline modification; doxazosin mesylate; modification designated; producing
Prior art date: 1999-03-18

Application number

PL00350088A

Other languages

English (en)

Inventor

Peter Klein

Marco Thyes

Original Assignee

Basf Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-18

Filing date

2000-03-06

Publication date

2002-11-04

2000-03-06 Application filed by Basf Ag filed Critical Basf Ag

2002-11-04 Publication of PL350088A1 publication Critical patent/PL350088A1/xx

Links

229960000220 doxazosin mesylate Drugs 0.000 title 1
VJECBOKJABCYMF-UHFFFAOYSA-N doxazosin mesylate Chemical compound [H+].CS([O-])(=O)=O.C1OC2=CC=CC=C2OC1C(=O)N(CC1)CCN1C1=NC(N)=C(C=C(C(OC)=C2)OC)C2=N1 VJECBOKJABCYMF-UHFFFAOYSA-N 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
238000012986 modification Methods 0.000 title 1
230000004048 modification Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

PL00350088A 1999-03-18 2000-03-06 Novel method for producing doxazosin mesylate in a crystalline modification designated as form a PL350088A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19912063A DE19912063A1 (de)	1999-03-18	1999-03-18	Neues Verfahren zur Herstellung von Doxazosin-Mesylat in einer als Form A bezeichneten Kristallmodifikation

Publications (1)

Publication Number	Publication Date
PL350088A1 true PL350088A1 (en)	2002-11-04

Family

ID=7901411

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL00350088A PL350088A1 (en)	1999-03-18	2000-03-06	Novel method for producing doxazosin mesylate in a crystalline modification designated as form a

Country Status (13)

Country	Link
EP (1)	EP1165548A1 (de)
JP (1)	JP2002540109A (de)
KR (1)	KR20010113753A (de)
CN (1)	CN1352643A (de)
AU (1)	AU3960800A (de)
CA (1)	CA2367903A1 (de)
CZ (1)	CZ20013347A3 (de)
DE (1)	DE19912063A1 (de)
HU (1)	HUP0200663A2 (de)
IL (1)	IL144944A0 (de)
PL (1)	PL350088A1 (de)
TR (1)	TR200102730T2 (de)
WO (1)	WO2000056731A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19912573A1 (de) *	1999-03-19	2000-09-21	Knoll Ag	Arzneimittel, enthaltend Doxazosin-Mesylat der Kristallmodifikaton D
RU2186779C1 (ru) *	2001-01-31	2002-08-10	Федеральное государственное унитарное предприятие Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей"	Способ получения метансульфоната доксазозина
NZ585558A (en) *	2007-12-24	2011-08-26	Cipla Ltd	Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof
CN109988158A (zh) *	2018-01-03	2019-07-09	合肥立方制药股份有限公司	X晶型、含有x晶型的多沙唑嗪甲磺酸盐及其制备方法和用途
CN111303130B (zh) *	2018-12-11	2021-09-14	合肥立方制药股份有限公司	一种多沙唑嗪甲磺酸盐晶型、其制备方法及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1287588B1 (it) *	1996-12-13	1998-08-06	Alfa Chem Ital	Forma cristallina del doxazosin mesilato e processo per la sua produzione
DE59611417D1 (de) *	1996-12-20	2007-03-29	Heumann Pharma Gmbh & Co	Neue polymorphe Form von Doxazosinmesylat (Form III)
DE19800214A1 (de) *	1998-01-06	1999-07-15	Knoll Ag	Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür

1999
- 1999-03-18 DE DE19912063A patent/DE19912063A1/de not_active Withdrawn
2000
- 2000-03-06 CZ CZ20013347A patent/CZ20013347A3/cs unknown
- 2000-03-06 CN CN00805209A patent/CN1352643A/zh active Pending
- 2000-03-06 JP JP2000606592A patent/JP2002540109A/ja active Pending
- 2000-03-06 CA CA002367903A patent/CA2367903A1/en not_active Abandoned
- 2000-03-06 TR TR2001/02730T patent/TR200102730T2/xx unknown
- 2000-03-06 HU HU0200663A patent/HUP0200663A2/hu unknown
- 2000-03-06 KR KR1020017011780A patent/KR20010113753A/ko not_active Withdrawn
- 2000-03-06 IL IL14494400A patent/IL144944A0/xx unknown
- 2000-03-06 EP EP00918763A patent/EP1165548A1/de not_active Withdrawn
- 2000-03-06 AU AU39608/00A patent/AU3960800A/en not_active Abandoned
- 2000-03-06 PL PL00350088A patent/PL350088A1/xx unknown
- 2000-03-06 WO PCT/EP2000/001939 patent/WO2000056731A1/de not_active Ceased

Also Published As

Publication number	Publication date
TR200102730T2 (tr)	2002-06-21
CZ20013347A3 (cs)	2002-01-16
CA2367903A1 (en)	2000-09-28
JP2002540109A (ja)	2002-11-26
CN1352643A (zh)	2002-06-05
DE19912063A1 (de)	2000-09-21
KR20010113753A (ko)	2001-12-28
IL144944A0 (en)	2002-06-30
HUP0200663A2 (en)	2002-08-28
EP1165548A1 (de)	2002-01-02
WO2000056731A1 (de)	2000-09-28
AU3960800A (en)	2000-10-09

Publication	Publication Date	Title
EG24141A (en)	2008-08-06	Method for preparing a composition
EG23017A (en)	2003-12-31	Method for producing brushware
HUP0105211A3 (en)	2003-08-28	Method for producing chlorine
IL140079A0 (en)	2002-02-10	Process for producing bisphennol a
PL365912A1 (en)	2005-01-10	Method for producing honeycomb structure
PL348858A1 (en)	2002-06-17	Method for producing l-phenylephrine hydrochloride
HUP0104566A3 (en)	2002-12-28	Process for producing n-carboxi-anhidrides
PL361146A1 (en)	2004-09-20	Method for producing isocyanato-organosilanes
HUP0102967A3 (en)	2003-01-28	Method for producing organosilylalkyl-polysulphanes
PL350088A1 (en)	2002-11-04	Novel method for producing doxazosin mesylate in a crystalline modification designated as form a
IL144264A0 (en)	2002-05-23	Process for producing quinolinecarbaldehyde
GB2345269B (en)	2002-06-19	Method for producing decorative tiles
IL144651A0 (en)	2002-05-23	Method for producing l-sorbose
AU2645900A (en)	2000-09-04	Method for producing a vwf preparation
GB2363379B (en)	2004-02-25	Process for producing alpha-aminoketones
AU4273501A (en)	2001-10-03	Process for producing camptothecin
IL146573A0 (en)	2002-07-25	Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
IL154825A0 (en)	2003-10-31	A METHOD FOR PRODUCING Delta1-PYRROLINES
EP1258331A4 (de)	2006-06-21	Verfahren zum herstellen von keramischen strukturen
AU7265900A (en)	2002-04-02	Method for producing otoplastics
HUP0203482A3 (en)	2005-11-28	Method for producing o-chloromethyl benzenecarbonyl chlorides
IL147804A0 (en)	2002-08-14	Method for producing 4-cyano-2-aminomethylthiazol
IL147769A0 (en)	2002-08-14	Method for producing 2-aminomethyl-4-cyano-thiazol
EP1304344A4 (de)	2004-11-24	Verfahren zur herstellung von polycarbonat
AU8444201A (en)	2002-03-22	Process for producing fluoroalkanol